Honoring the efforts of Dr. Sioufi, a champion for social justice and health equity

After two years of complete redesign, Tribun Health is proud to announce the release of TeleSlide Patho 5.

World's first amplified lateral flow rapid test combines the accuracy and early detection of central lab testing with the simplicity, speed, and low cost of traditional lateral flow tests

FDA clearance of HEp-2 ANA IFA test system on the dIFine system includes positive and negative determination and 8 common ANA HEp-2 staining patterns.

The Tribun Health executive team is growing with the creation of a VP Pharma position to develop the expanding pharmaceutical business.

Targeting the world's future viruses

TEAL products offer high performance power conditioning and distribution for demanding applications.

Educating community residents about the importance of screening and early detection of Colorectal Cancer as part of Whittier's efforts to promote health equity.

Nonprofit Group Seeks Remedy for Decades of Inaccurate Lyme Disease Testing

The company wins the prestigious 'Best in Klas' award

National ad campaign will encourage patients to ask doctors about superior NGS diagnostics

Inanovate hires new CEO to help drive next phase of growth and bring novel new blood testing technology for cancer into the clinic.

Transformational Patient Experience

Efforts are underway to spread cheer and give back to their community this holiday season.

Patients can now receive a diagnosis of IBS or other disorders of gut-brain interaction and begin treatment sooner through use of this criteria designed only for clinical use.

A new level of accuracy and specificity in allergy testing is now available. Easy to use and affordable, AllerSmart IgE allows people to take charge of their healthcare and make the first move. The 9 "Big Foods" tested, such as peanut, account for 90% of true food allergy - 29 key environmentals such as grass, dust mite, trees, weeds, cat, dog and molds complete the screen. This should not be confused with sensitivity or intolerance testing.

Could Hold the Clue to Creating Better Treatments for Rheumatoid Arthritis

Expanding their mission-based diagnostics services

Investment to be utilized for scaling the company and commercialization of Qsant™, a urine test that monitors the health of transplanted kidneys

Funding Supports Continued Development of the SensiTox™ B. anthracis Toxin Test

The health tech company Digital Diagnostics AG from Mainz, Germany, has received approval for clinical trials from a German ethics committee and the Federal Institute for Drugs and Medical Devices (BfArM). This is a crucial regulatory step in the ongoing approval process for the Digid Cantisense™ SARS-CoV-2 test in Germany. The aim of the clinical trials is to demonstrate the reliability of the new technology in comparison with conventional PCR tests. The new test is particularly suitable for access control at airports or at large-scale event

Abbas Vafai, Ph.D. inventor of shingles vaccine, Shingrix™, develops ZosterGent™ VZV Identification Reagent, a more sensitive test in detecting the shingles virus.

Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to further advance its biomarker discovery platform.